July 2026
Published Jul 18, 2026RCTs
This study evaluated the effectiveness of a Family Health Nurse model on diabetes self-management in middle-aged women, finding significant improvements in self-management scores and reductions in HbA1c levels.
Interventions
Family health nurse model intervention
Outcomes
Diabetes self-management behaviorsHbA1c
Added to Dediabetes Jul 18, 2026
Published Jul 18, 2026RCTs
Ebenatide treatment significantly improved glycemic control and body composition in participants with Type 2 Diabetes Mellitus over 52 weeks.
Outcomes
BMIBlood glucoseBody fat mass+10 more
Added to Dediabetes Jul 18, 2026
Published Jul 18, 2026RCTs
A quinoa-based dietary intervention improved glycemic control in patients with early-stage type 2 diabetes mellitus.
Interventions
Standard diet
Outcomes
Glucose iAUC (OGTT)HbA1cPostprandial blood glucose+2 more
Added to Dediabetes Jul 18, 2026
Published Jul 18, 2026RCTs
This study evaluated the hypoglycemic effects of topical Citrullus colocynthis fruit extract in individuals with type 2 diabetes, showing significant blood glucose reduction without adverse effects.
Interventions
Topical Citrullus colocynthis (bitter apple) fruit extract
Outcomes
Blood glucoseSkin toxicity or adverse complaints
Added to Dediabetes Jul 18, 2026
Published Jul 18, 2026RCTs
This study evaluated the efficacy of fermented deglycyrrhizinated licorice (FDGL) in treating early-stage diabetic polyneuropathy, showing significant improvements in nerve conduction velocities and vibration perception.
Interventions
FDGL capsules
Outcomes
Change in motor nerve conduction velocity (MCV) from baselineChange in sensory nerve conduction velocity from baselineChange in vibration perception threshold+2 more
Added to Dediabetes Jul 18, 2026
Published Jul 18, 2026RCTs
This study compared once-weekly efsitora to once-daily degludec in reducing HbA1c levels in Japanese adults with type 2 diabetes, finding comparable efficacy.
Interventions
EfsitoraInsulin degludec
Outcomes
HbA1cSevere hypoglycemiaTime in range
Added to Dediabetes Jul 18, 2026
Published Jul 17, 2026RCTs
This Phase III trial compared Liraglutide Biosimilar with reference Liraglutide, finding both effective in reducing body weight and improving glycemic control.
Outcomes
Body weightFasting Plasma Glucose (FPG)Glucose iAUC (OGTT)+1 more
Added to Dediabetes Jul 17, 2026
Published Jul 17, 2026RCTs
This study examined the long-term effects of the Tübingen Lifestyle Intervention Program on glycemia and insulin secretion in individuals at high risk for type 2 diabetes, revealing significant increases in fasting plasma glucose and 2-hour plasma glucose levels among certain participants.
Interventions
Lifestyle intervention for prediabetes
Outcomes
2-hour plasma glucoseFasting Plasma Glucose (FPG)Insulin secretion levels after Roux-en-Y gastric bypass surgery+1 more
Added to Dediabetes Jul 17, 2026
Published Jul 17, 2026RCTs
This study investigated the anti-aging effects of Henagliflozin in patients with Type 2 diabetes, finding an increase in telomere length and other biomarkers.
Interventions
Henagliflozin
Outcomes
Granzyme B expression in cytotoxic T lymphocytes increasedIncreased Thiamine LevelsInsulin-like growth factor-binding protein-3 levels+4 more
Added to Dediabetes Jul 17, 2026
Published Jul 17, 2026RCTs
This study examined the effects of time-restricted eating on mood and quality of life in adults with type 2 diabetes, finding significant weight loss in the TRE group.
Interventions
Calorie restrictionTime-Restricted Eating (TRE)
Outcomes
Body fat massBody weightDepression score+3 more
Added to Dediabetes Jul 17, 2026